中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2010年
1期
33-36
,共4页
郝建磊%李瑞英%庞青松%王平
郝建磊%李瑞英%龐青鬆%王平
학건뢰%리서영%방청송%왕평
乳腺肿瘤/外科学%乳腺肿瘤/放射疗法%放射疗法%术后%预后
乳腺腫瘤/外科學%乳腺腫瘤/放射療法%放射療法%術後%預後
유선종류/외과학%유선종류/방사요법%방사요법%술후%예후
Breast neoplasms/surgery%Breast neoplasms/radiotherapy%Radiotherapy,postop-erative%Prognosis
目的 探讨早期乳腺癌患者根治术后是否需要接受放疗.方法 回顾性分析本院1998年根治术后经病理证实腋窝淋巴结0~3个阳性的乳腺癌患者270例,其中腋窝淋巴结阴性者156例,腋窝淋巴结转移1、2、3个的分别为60、30、24例(114例).定义预后指数≥4分者为高危患者,<4分者为低危患者.生存率计算采用Kaplan-Meier法并Logrank检验.结果 腋窝淋巴结阴性与1~3阳性者10年生存率、10年无瘤生存率、平均无瘤生存时间、局部复发率、远处转移率分别为75.0%与63.2%(χ~2=4.40,P=0.036),71.2%与59.6%(χ~2=3.90,P=0.048)、(97.03±2.53)个月与(87.01±3.80)个月(t=2.28,P=0.023)、7.7%与16.7%(χ~2=5.22,P=0.022)、12.8%与21.1%(χ~2=3.27,P=0.070).高危组中未放疗者和放疗者的10年生存率分别为56%和72%(χ~2=4.07,P:0.044),局部复发率分别为24%和5%(χ~2=11.16,P=0.001),远处转移率分别为26%和16%(χ~2=2.18,P=0.140).低危组未放疗和放疗者10年生存率分别为71%和81%(χ~2=1.57,P=0.210),局部复发率分别为11%和11%(χ~2=0.01,P=0.975),远处转移率分别为13%和13%(χ~2=0.00,P=1.000).结论 T_1~T_2期腋窝淋巴结1~3个阳性乳腺癌患者根治术后可考虑放疗,预后指数的应用似乎可选择那些复发概率较大患者,从而尽量减少一部分患者接受不必要放疗.
目的 探討早期乳腺癌患者根治術後是否需要接受放療.方法 迴顧性分析本院1998年根治術後經病理證實腋窩淋巴結0~3箇暘性的乳腺癌患者270例,其中腋窩淋巴結陰性者156例,腋窩淋巴結轉移1、2、3箇的分彆為60、30、24例(114例).定義預後指數≥4分者為高危患者,<4分者為低危患者.生存率計算採用Kaplan-Meier法併Logrank檢驗.結果 腋窩淋巴結陰性與1~3暘性者10年生存率、10年無瘤生存率、平均無瘤生存時間、跼部複髮率、遠處轉移率分彆為75.0%與63.2%(χ~2=4.40,P=0.036),71.2%與59.6%(χ~2=3.90,P=0.048)、(97.03±2.53)箇月與(87.01±3.80)箇月(t=2.28,P=0.023)、7.7%與16.7%(χ~2=5.22,P=0.022)、12.8%與21.1%(χ~2=3.27,P=0.070).高危組中未放療者和放療者的10年生存率分彆為56%和72%(χ~2=4.07,P:0.044),跼部複髮率分彆為24%和5%(χ~2=11.16,P=0.001),遠處轉移率分彆為26%和16%(χ~2=2.18,P=0.140).低危組未放療和放療者10年生存率分彆為71%和81%(χ~2=1.57,P=0.210),跼部複髮率分彆為11%和11%(χ~2=0.01,P=0.975),遠處轉移率分彆為13%和13%(χ~2=0.00,P=1.000).結論 T_1~T_2期腋窩淋巴結1~3箇暘性乳腺癌患者根治術後可攷慮放療,預後指數的應用似乎可選擇那些複髮概率較大患者,從而儘量減少一部分患者接受不必要放療.
목적 탐토조기유선암환자근치술후시부수요접수방료.방법 회고성분석본원1998년근치술후경병리증실액와림파결0~3개양성적유선암환자270례,기중액와림파결음성자156례,액와림파결전이1、2、3개적분별위60、30、24례(114례).정의예후지수≥4분자위고위환자,<4분자위저위환자.생존솔계산채용Kaplan-Meier법병Logrank검험.결과 액와림파결음성여1~3양성자10년생존솔、10년무류생존솔、평균무류생존시간、국부복발솔、원처전이솔분별위75.0%여63.2%(χ~2=4.40,P=0.036),71.2%여59.6%(χ~2=3.90,P=0.048)、(97.03±2.53)개월여(87.01±3.80)개월(t=2.28,P=0.023)、7.7%여16.7%(χ~2=5.22,P=0.022)、12.8%여21.1%(χ~2=3.27,P=0.070).고위조중미방료자화방료자적10년생존솔분별위56%화72%(χ~2=4.07,P:0.044),국부복발솔분별위24%화5%(χ~2=11.16,P=0.001),원처전이솔분별위26%화16%(χ~2=2.18,P=0.140).저위조미방료화방료자10년생존솔분별위71%화81%(χ~2=1.57,P=0.210),국부복발솔분별위11%화11%(χ~2=0.01,P=0.975),원처전이솔분별위13%화13%(χ~2=0.00,P=1.000).결론 T_1~T_2기액와림파결1~3개양성유선암환자근치술후가고필방료,예후지수적응용사호가선택나사복발개솔교대환자,종이진량감소일부분환자접수불필요방료.
Objective To study whether post-operative radiotherapy is necessary for patients with early breast cancer after radical mastectomy. Methods In 1998, 270 early breast cancer patients with 0 -3 pathologically confirmed positive axillary lymph nodes after radical mastectomy were retrospectively ana-lyzed. There were 156 patients with negative lymph node and 114 with 1 -3 positive lymph nodes. The prog-nostic index (PI) was defined as the sum of scores of the tumor size, number of positive axillary lymph nodes, receptor status, surgical margin status, lymphatic thrombi status, pathological grading and age. The PI≥ 4 was considered as high-risk, and PI <4 as the low-risk. Numerical variables were compared using t test and categorical variables were compared using chi-square test. Kaplan-Meier method was used to calcu-late the survival rates, and the Log-rank test was used for the comparison of the survival curves between dif-ferent groups. Results Of the patients with lymph node negative and 1 - 3 positive, the survival rates were 75.0% and 63.2% (χ~2 = 4.40 ,P =0.036), respectively. The corresponding disease-free survival rate, lo-cal recurrence rate, distant metastasis rate were 71.2% and 9.6% (χ~2 = 3.90, P = 0.048), 7.7% and 16.7%(χ~2 =5.22,P=0.022),12.8% and 21.1%(χ~2=3.27,P=0.070), respectively. The mean dis-ease-free survival time of the two groups was 97.03 ± 2.53 months and 87.01 ± 3.80 months, respectively. In the high-risk group, the 10-year survival rates of patients with and without radiotherapy were 72% and 56% (χ~2 = 4.07, P = 0.044), the local recurrence rates were 5% and 24% (χ~2= 11.16, P = 0. 001), and the distant metastasis rates were 16% and 26% (χ~2= 2.18 ,P = 0. 140). In the low-risk group, the survival rate of patients with and without radiotherapy were 81% and 71% (χ~2 = 1.57 ,P = 0.210), the local recur-rence rates were both 11% (χ~2=0.01 ,P=0.975), and the distant metastasis rates were both 13% (χ~2 = 0.00,P = 1. 000). Conclusions Early breast cancer patients with 1 -3 positive axiilary lymph nodes should receive post-operative radiotherapy after radical mastectomy. The prognostic index may decrease the chance of unnecessary radiation by distinguishing the patients under low risk of recurrence from those under high risk.